Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje
Iingcaphuno zeStock zeenkampani ezingama-71229 ngexesha langempela.
Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje

Iingcaphuno zempahla

Imali icatshulwa kwi-intanethi

Imbali icatshulwa ngemali

Imali yerhwebo yemali

Izabelo zeStock

Inzuzo kwizabelo zenkampani

Iingxelo zemali

Izabelo zezabelo zeenkampani. Kuphi utyalo mali?

Seres Therapeutics, Inc. ikhonkco yemakethe

Umthamo wokuthengwa kweempahla Seres Therapeutics, Inc. namhlanje kunye nembali yentlawulo ye-Seres Therapeutics, Inc. ukususela ekuqaleni kokuthengisa kwiMCRB izabelo kwi-stock exchange.
Yongeza kumajethijethi
Ukongezwa kumajethi

Seres Therapeutics, Inc. i-capital capital

Namhlanje i-market capital Seres Therapeutics, Inc. ingu-664 519 104 US dollar.
+3 643 136 $ (+0.55%)
utshintsho lwentengo ukususela ngezolo

Seres Therapeutics, Inc. capitalization kwi-intanethi namhlanje kwiidola. Yonke imihla, sirekhoda utshintsho kwi-Seres Therapeutics, Inc. capitalization. Seres Therapeutics, Inc. ingxowankulu ulwazi oluvulekileyo. Seres Therapeutics, Inc. ikhonkco yentengiso namhlanje yi- $ 664 519 104.

Seres Therapeutics, Inc. ivolumu yezorhwebo

Namhlanje inani lemali yokuthengisa Seres Therapeutics, Inc. lingama-826 107 US dollar.
-4 095 309 $ (-83.21%)
utshintsho lwendleko yorhwebo ukususela ngezolo

Seres Therapeutics, Inc. iivolumu zorhwebo namhlanje zifikelele kwi $ 826 107. Namhlanje, Seres Therapeutics, Inc. kwenzeke kwiimarike ezahlukeneyo zesitokhwe. Seres Therapeutics, Inc. yokuthengisa kwiwebhusayithi yethu yonke imihla. Seres Therapeutics, Inc. itekhs yentengiso yonyuke ngo- $ 3 643 136.

Bonisa:
Ukuze

Seres Therapeutics, Inc. istatshi yekhredithi yemakethe

Seres Therapeutics, Inc. eyinkunzi yentengiso kwigrafu ngeminyaka. -19.29% - utshintsho olwenziwayo kwi-capital capital ye Seres Therapeutics, Inc. ngeveki. 0% ngenyanga - utshintsho kwimali eyenziweyo Seres Therapeutics, Inc.. Seres Therapeutics, Inc. capitalisation inyukile xa ithelekiswa nezolo.

Iveki Inyanga iinyanga 3 Unyaka Iminyaka emithathu

Seres Therapeutics, Inc. imbali yenkxaso-mali

Umhla Ixabiso
Imali-mali (intengo-mali yemarike) yixabiso lemarike yazo zonke izabelo zeenkampani ezithengiswa kwi-stock exchange. Imali yentengo yemali ilingana nexabiso lezabelo ezandisiwe ngenani lezabelo ezikhoyo.
04/05/2023 664 519 104 $
03/05/2023 660 875 968 $
02/05/2023 598 239 680 $
01/05/2023 622 527 232 $
28/04/2023 633 840 064 $
27/04/2023 718 386 240 $
26/04/2023 823 313 920 $

Seres Therapeutics, Inc. isatifiketi somqulu

Iveki Inyanga iinyanga 3 Unyaka Iminyaka emithathu

Seres Therapeutics, Inc. idatha yembali yevolumu

Umhla Umqulu (24h)
Ixabiso lezorhwebo leSeres Therapeutics, Inc. izabelo yintlawulo yenani lazo zonke iintengiso kunye neengxenye ze-MCRB ezithengiweyo kwaye zathengiswa ngexesha lomhla okhethiweyo.
04/05/2023 826 107 $
03/05/2023 4 921 416 $
02/05/2023 1 687 489 $
01/05/2023 6 222 375 $
28/04/2023 7 483 019 $
27/04/2023 8 892 779 $
26/04/2023 4 389 674 $

Seres Therapeutics, Inc. i-capitalisation yentengiso kwi 04/05/2023 ilingana ne 664 519 104 iidola zaseMelika. Seres Therapeutics, Inc. capitalization ilingane 660 875 968 Iidola zaseMelika ku- 03/05/2023. Seres Therapeutics, Inc. capitalization e 02/05/2023 ifikelele kuthi 598 239 680 iidola zaseMelika. 01/05/2023 Seres Therapeutics, Inc. capitalised eyi- 622 527 232 iidola zaseMelika.

Seres Therapeutics, Inc. capitalization e 28/04/2023 ifikelele kuthi 633 840 064 iidola zaseMelika. Iimali yentengiso enkulu ye Seres Therapeutics, Inc. kwi 27/04/2023 ifikelele kuthi 718 386 240 iidola zaseMelika. Seres Therapeutics, Inc. capitalisation yimali eyi- $ 823 313 920 kwi 26/04/2023.

Inkcitho ye-Seres Therapeutics, Inc. namhlanje ngu-664 519 104 $. Iimali zentengiso ye-Seres Therapeutics, Inc. ishintshile +0.55% xa kuthelekiswa nezolo. Imali yokuthengisa ye MCRB izabelo ze Seres Therapeutics, Inc. ngosuku lokugqibela lokurhweba lilinganiselwa kuma-826 107 $. Ixabiso lokuthengiswa kwezabelo ze Seres Therapeutics, Inc. latshintshile kwi--83.214% xa kuthelekiswa nosuku lwangaphambili lworhwebo.

Iindleko zezabelo Seres Therapeutics, Inc.